All announcements for “PHARMA”
Date Category Title Ref
09/09/2021 Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) CS2-09092021-00006
06/09/2021 Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) CS2-06092021-00083
03/09/2021 Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) CS2-03092021-00011
30/08/2021 Change in Audit Committee Change in Audit Committee C02-26082021-00018
27/08/2021 Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) CS2-27082021-00077
26/08/2021 Change in Audit Committee Change in Audit Committee C02-26082021-00016
26/08/2021 Change in Boardroom Change in Boardroom C03-26082021-00005
24/08/2021 Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) CS2-24082021-00054
20/08/2021 Financial Results Quarterly rpt on consolidated results for the financial period ended 30 Jun 2021 FRA-20082021-00042
20/08/2021 Change in Boardroom Change in Boardroom C03-20082021-00005